Non-nucleoside inhibitors of HCV polymerase NS5B. Part 3: synthesis and optimization studies of benzothiazine-substituted tetramic acids
de Vicente, J., Hendricks, R.T., Smith, D.B., Fell, J.B., Fischer, J., Spencer, S.R., Stengel, P.J., Mohr, P., Robinson, J.E., Blake, J.F., Hilgenkamp, R.K., Yee, C., Zhao, J., Elworthy, T.R., Tracy, J., Chin, E., Li, J., Lui, A., Wang, B., Oshiro, C., Harris, S.F., Ghate, M., Leveque, V.J., Najera, I., Le Pogam, S., Rajyaguru, S., Ao-Ieong, G., Alexandrova, L., Fitch, B., Brandl, M., Masjedizadeh, M., Wu, S.Y., de Keczer, S., Voronin, T.(2009) Bioorg Med Chem Lett 19: 5648-5651
- PubMed: 19700319 
- DOI: 10.1016/j.bmcl.2009.08.023
- Primary Citation of Related Structures:  
3H59 - PubMed Abstract: 
Benzothiazine-substituted tetramic acids were discovered as highly potent non-nucleoside inhibitors of HCV NS5B polymerase. X-ray crystallography studies confirmed the binding mode of these inhibitors with HCV NS5B polymerase. Rational optimization of ti ...